2014 Physicians Safety Specialization 
Pharmaceutical Technology
JANUARY 23, 2023
In recent years, with the advent of biologics and novel therapeutic targets such as anti-TNF, anti-interleukin, and anti-integrin, there has been a steady increase in the number of agents approved to treat inflammatory bowel diseases (IBD), which has provided physicians with an increasing number of options to treat Crohn’s disease (CD).
pharmaphorum
DECEMBER 14, 2022
In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 19, 2023
16 Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions” Vaccines and other drugs for rapid and safe worldwide distribution should be free from the need for special storage conditions. Injection Safety Fact Sheet. at 100°C for 24 hours.
pharmaphorum
OCTOBER 26, 2022
Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An But rare diseases are a particularly important and challenging focus area.
Evolve Your Success
MAY 10, 2022
We have with us two special individuals by the name of Karen DiMarco and Antra Boyd. I was done clinical nursing in 2014. Physicians and providers like it because people are engaged in their care. In the hierarchy in OR, I understand that the physician is the lead of a team, which is fine. Listen to the podcast here.
Evolve Your Success
FEBRUARY 6, 2024
— Watch the episode here Listen to the podcast here Medical Sales In Sterile Processing And Infection Prevention With Mark Copeland We have with us another special guest and he goes by the name of Mark Copeland. I left them in 2014 to start our own thing. Patient safety is to do no harm. Probably right around it.
Clarify Health
MARCH 15, 2023
Some of the key elements the group shared for building trust were: personalizing programs to fit the strengths of the providers, having shared data and insights that everyone trusts, and providing timely and actionable insights about how to improve outcomes that don’t disrupt physician work streams.
Expert insights. Personalized for you.
59 
Let's personalize your content